Get started
Author

Payge Van Stechelman

Observed name: P. Van Stechelman
ORCID: 0009-0002-2295-2961
Observed ORCID: 0009-0002-2295-2961
OpenAlex ID: A5093230299
Direct challenges are safe and effective in children with low-risk allergies to oral cephalosporins
2025 · Christine R.F. Rukasin, Timothy G. Chow, et al. · The Journal of Allergy and Clinical Immunology In Practice · 2
PDF
Dominant‐negative CARD11 loss‐of‐function variant presenting with hypereosinophilic syndrome
2023 · Bridget E. Wilson, Payge Van Stechelman, et al. · Pediatric Allergy and Immunology · 2
Hypogammaglobulinemia in 2 children with Zhu-Tokita-Takenouchi-Kim syndrome
2024 · Payge Van Stechelman, Bridget Wilson, et al. · Annals of Allergy Asthma & Immunology · 1
Can It Be Done in One Day? Pediatric Patients With Multiple Drug Allergy Labels: a Retrospective Analysis
2026 · Ashnaa Rao, Payge Van Stechelman, et al. · Journal of Allergy and Clinical Immunology
PDF
Clinical Predictors of Confirmed Beta-lactam Anaphylaxis: A Multivariable Analysis
2026 · Payge Van Stechelman, Josue Valdez, et al. · Journal of Allergy and Clinical Immunology
Safety of Direct Cephalosporin Oral Challenges in Children
2025 · Christine Rukasin, Payge Van Stechelman, et al. · Journal of Allergy and Clinical Immunology
Building a Pediatric Drug Allergy Evaluation Program
2023 · P. Van Stechelman, A. Rao, et al. · Annals of Allergy Asthma & Immunology
Author response for "Dominant‐negative CARD11 loss‐of‐function variant presenting with hypereosinophilic syndrome"
2023 · Bridget E. Wilson, Payge Van Stechelman, et al. · Publons reviews and discussion
Works count: 8
Citation count: 5
H-index: 2
I10-index:
Year
Topic
Type